![Els Hubloux](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Els Hubloux
Director de Inversiones en QUEST FOR GROWTH NV .
Cargos activos de Els Hubloux
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
QUEST FOR GROWTH NV | Director de Inversiones | - | - |
Newton Biocapital Partners SRL
![]() Newton Biocapital Partners SRL Investment ManagersFinance Newton Biocapital Partners SPRL is an Independent Venture Capital firm founded in 2017 by Alain Parthoens. Newton Biocapital Partners SPRL is headquartered in Woluwe-Saint-Pierre. | Inversor de Capital Privado | 04/04/2017 | - |
DeuterOncology SA
![]() DeuterOncology SA BiotechnologyHealth Technology DeuterOncology SA is a Belgian preclinical-stage biotechnology company that specializes in developing targeted cancer therapies. DeuterOncology is based in Liege, BE. The company's focus is on creating a first-in-class dual MET and RAS pathway inhibitor. The company was founded in 2020 by Timothy Perera, who has been the CEO since 2020. | Director/Miembro de la Junta | - | - |
Historial de carrera de Els Hubloux
Antiguos cargos conocidos de Els Hubloux.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
QBIC Venture Partners BV
![]() QBIC Venture Partners BV Investment ManagersFinance QBIC Venture Partners BVBA (QBIC Venture Partners) is a venture capital firm founded in 2012 by Marc Zabeau. The firm is headquartered in Belgium. | Inversor de Capital Privado | 23/05/2012 | 31/12/2016 |
Capricorn Partners NV
![]() Capricorn Partners NV Investment ManagersFinance Capricorn Partners NV (Capricorn) is an independent European licensed manager of private and public equity investment funds which was founded in 1993 as a joint venture between Dr Jos B. Peeters and Baring Venture Partners Ltd. In 1999, Capricorn became a fully partner-owned, independent firm. It is headquartered in Leuven, Belgium. | Inversor de Capital Privado | 21/10/2009 | 23/05/2012 |
Quest Management SA (Private Equity)
![]() Quest Management SA (Private Equity) Investment ManagersFinance Quest Management NV/SA is an independent partner-owned investment management firm specialized in emerging technologies and life sciences. Quest was established in 1998 with the venture capital firm Capricorn Venture Partner as a co-founder, and is located in Leuven in the Flemish region of Belgium. Quest manages Luxembourg-domiciled funds, including a US dollar-denominated SICAV and the Belgian collective private equity investment vehicle Quest for Growth (XB: QFG), which was the first investment company set up as a tax-advantaged Privak. | Inversor de Capital Privado | 01/07/2007 | 21/10/2009 |
KBC Securities NV
![]() KBC Securities NV Investment Banks/BrokersFinance KBC Securities NV is a broker/dealer firm headquartered in Brussels, Belgium. The firm was founded in 1998 and is a wholly owned subsidiary of KBC Bank NV, itself a subsidiary of KBC Groupe SA (EBR: KBC). KBC Securities provides liquidity and order execution services to institutional clients internationally, from investment banks to mutual funds and private investors. | Analyst-Equity | 20/02/2003 | 20/02/2003 |
MyCartis NV
![]() MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Director Financiero/CFO | - | - |
Tc Land Expression SA
![]() Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Director/Miembro de la Junta | - | - |
░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formación de Els Hubloux.
Vrije Universiteit Brussel | Masters Business Admin |
Estadísticas
Internacional
Bélgica | 10 |
Reino Unido | 2 |
Francia | 2 |
Operativa
Private Equity Investor | 4 |
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Sectorial
Finance | 7 |
Health Technology | 3 |
Producer Manufacturing | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 10 |
---|---|
Abbott Group Ltd.
![]() Abbott Group Ltd. Building ProductsProducer Manufacturing Abbott Group Ltd. manufactures doors and timber products. It specializes in the supply of fenestration products to homebuilders. The company's products include PVC-U windows, doors and cavity closers. Abbott Group is headquartered in Halisham, UK | Producer Manufacturing |
Tc Land Expression SA
![]() Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Commercial Services |
Quest Management SA (Private Equity)
![]() Quest Management SA (Private Equity) Investment ManagersFinance Quest Management NV/SA is an independent partner-owned investment management firm specialized in emerging technologies and life sciences. Quest was established in 1998 with the venture capital firm Capricorn Venture Partner as a co-founder, and is located in Leuven in the Flemish region of Belgium. Quest manages Luxembourg-domiciled funds, including a US dollar-denominated SICAV and the Belgian collective private equity investment vehicle Quest for Growth (XB: QFG), which was the first investment company set up as a tax-advantaged Privak. | Finance |
Capricorn Partners NV
![]() Capricorn Partners NV Investment ManagersFinance Capricorn Partners NV (Capricorn) is an independent European licensed manager of private and public equity investment funds which was founded in 1993 as a joint venture between Dr Jos B. Peeters and Baring Venture Partners Ltd. In 1999, Capricorn became a fully partner-owned, independent firm. It is headquartered in Leuven, Belgium. | Finance |
KBC Securities NV
![]() KBC Securities NV Investment Banks/BrokersFinance KBC Securities NV is a broker/dealer firm headquartered in Brussels, Belgium. The firm was founded in 1998 and is a wholly owned subsidiary of KBC Bank NV, itself a subsidiary of KBC Groupe SA (EBR: KBC). KBC Securities provides liquidity and order execution services to institutional clients internationally, from investment banks to mutual funds and private investors. | Finance |
Quest for Growth NV
![]() Quest for Growth NV Investment ManagersFinance Quest for Growth NV, a fund traded on Euronext Brussels, has a diversified portfolio which is invested in growth companies listed on European stock exchanges, in European unquoted companies and in venture capital funds. It targets companies operating in the fields of healthcare, healthy living, well-being, human development, smart industries, digitalisation and clean technology & sustainable chemistry. It provides financing for growth stage capital requirements. It also makes co-investments. | Finance |
MyCartis NV
![]() MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Health Technology |
QBIC Venture Partners BV
![]() QBIC Venture Partners BV Investment ManagersFinance QBIC Venture Partners BVBA (QBIC Venture Partners) is a venture capital firm founded in 2012 by Marc Zabeau. The firm is headquartered in Belgium. | Finance |
Newton Biocapital Partners SRL
![]() Newton Biocapital Partners SRL Investment ManagersFinance Newton Biocapital Partners SPRL is an Independent Venture Capital firm founded in 2017 by Alain Parthoens. Newton Biocapital Partners SPRL is headquartered in Woluwe-Saint-Pierre. | Finance |
DeuterOncology SA
![]() DeuterOncology SA BiotechnologyHealth Technology DeuterOncology SA is a Belgian preclinical-stage biotechnology company that specializes in developing targeted cancer therapies. DeuterOncology is based in Liege, BE. The company's focus is on creating a first-in-class dual MET and RAS pathway inhibitor. The company was founded in 2020 by Timothy Perera, who has been the CEO since 2020. | Health Technology |
- Bolsa de valores
- Insiders
- Els Hubloux
- Experiencia